Cargando…
Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
National Academy of Sciences
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522324/ https://www.ncbi.nlm.nih.gov/pubmed/36122248 http://dx.doi.org/10.1073/pnas.2214620119 |
| _version_ | 1784800039693975552 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9522324 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | National Academy of Sciences |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95223242022-09-30 Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile Proc Natl Acad Sci U S A Correction National Academy of Sciences 2022-09-19 2022-09-27 /pmc/articles/PMC9522324/ /pubmed/36122248 http://dx.doi.org/10.1073/pnas.2214620119 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Correction Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile |
| title | Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile |
| title_full | Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile |
| title_fullStr | Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile |
| title_full_unstemmed | Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile |
| title_short | Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced T(reg) depletion shows excellent preclinical efficacy and safety profile |
| title_sort | correction for gan et al., an anti-ctla-4 heavy chain–only antibody with enhanced t(reg) depletion shows excellent preclinical efficacy and safety profile |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522324/ https://www.ncbi.nlm.nih.gov/pubmed/36122248 http://dx.doi.org/10.1073/pnas.2214620119 |